在英国生物银行估计的小密集的LDL胆固醇和动脉样性心血管风险
Rafael Zubiran1, Maureen Sampson2, Anna Wolska1
1Lipoprotein Metabolism Laboratory, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. (R.Z., A.W., A.T.R.).
Arteriosclerosis, thrombosis, and vascular biology
|August 14, 2025
概括
估计的小型,密集的低密度脂蛋白胆固醇 (E-sdLDL-C) 比传统标志物更好地预测动脉样硬化心血管疾病 (ASCVD) 风险. 这种可访问的测试可以通过更准确地识别高风险个体来增强初级预防策略.
科学领域:
- 心血管医学 心血管医学
- 脂质学 脂质学是指脂质学.
- 预防性心脏病学 预防性心脏病学
背景情况:
- 动脉样性心血管疾病 (ASCVD) 风险评估对于初级预防至关重要.
- 风险增强剂测试增强了传统标记,以改善ASCVD风险预测.
- 估计的小,密集的低密度脂蛋白胆固醇 (E-sdLDL-C) 被调查为潜在的风险增强剂.
研究的目的:
- 为了确定E-sdLDL-C是否可以改善ASCVD风险评估.
- 评估E-sdLDL-C作为一种用于初级预防的新型风险增强剂测试.
主要方法:
- 对271,760名没有先前ASCVD或降脂药物的英国生物库参与者的前性队列分析.
- 随访时间中位数为10年,主要结论是所有原因的ASCVD发病率.
- 统计分析包括多变量调整和危险比率计算.
主要成果:
- E-sdLDL-C与ASCVD事件有很强的关联 (HR 1.23).
- 经过调整后,E-sdLDL-C和阿波蛋白B (ApoB) 仍然是显著的脂质风险因素.
- 当异调时,E-sdLDL-C比LDL-C和ApoB更具预测性,这表明ASCVD风险更高.
结论:
- 与LDL-C相比,E-sdLDL-C在初级预防中提供了优越的ASCVD风险预测.
- 可以从标准脂质面板计算E-sdLDL-C,这可能会在没有额外测试的情况下改善ASCVD风险评估.
- 将高E-sdLDL-C与其他风险增强剂相结合,进一步增加ASCVD风险.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
293
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
293
Cholesterol: Significance and Regulation
686
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
686
Lipids: Dietary Sources and Requirements
1.1K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.1K
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Atherosclerosis I: Introduction
82
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
82
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55


